ewsba.se
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:
Fox Advisors upgraded Uber (UBER) to Outperform from Equal-Weight with a $95 price target. The firm thinks a heavier rate of investment over the past year is "poised to more consistently contribute to profit growth."
Raymond James upgraded Terex (TEX) to Strong Buy from Outperform with an unchanged price target of $85. The firm left the company's Q1 report with greater conviction that its materials processing earnings are likely to accelerate through 2026.
Macquarie upgraded News Corp. (NWS, NWSA) to Outperform from Neutral with a price target of $29.40, up from $27. Fiscal Q3 showed growth across revenue and EBITDA ahead of Visible Alpha consensus, notes the firm, which notes that News Corp. is executing on AI content license deals, reinforcing the proprietary nature of its data and providing earnings benefits.
Argus upgraded Fortive (FTV) to Buy from Hold with a $68 price target after its Q1 results. The firm noted it had been looking for more transparency on top-line growth as a potential upgrade trigger, and the company's Q1 results indicated solid sequential growth.
BofA upgraded Pitney Bowes (PBI) to Neutral from Underperform with a price target of $16.50, up from $9.50, following better-than-expected Q1 results. Given its view that Pitney Bowes is "beginning to turn a corner" on stabilizing revenue declines, coupled with meaningful cost take-out since 2024 and robust share buybacks, the firm is more confident on operating earnings growth and capital return, but sees shares as discounting much of a potential turnaround with the stock up about 50% year-to-date.
UBS downgraded Dell Technologies (DELL) to Neutral from Buy with a price target of $243, up from $167. The stock's risk/reward going forward is more balanced following the 170% rally over the past 12 months, the firm tells investors in a research note.
HSBC downgraded Trade Desk (TTD) to Reduce from Hold with a price target of $20, down from $31. Trade Desk's weaker outlook reflects slower growth driven by rising competition from Amazon's (AMZN) DSP, AI-driven shifts away from the open web, and escalating friction with major ad agencies that are increasingly restricting platform usage, creating downside risk to both ad spend and take rates, the firm tells investors in a research note.
BNP Paribas downgraded HubSpot (HUBS) to Neutral from Outperform with a $210 price target. Q1 results have cast uncertainty on market expectations for faster top-line growth this year, the analyst tells investors.
JPMorgan downgraded Wendy's (WEN) to Underweight from Neutral with a price target of $6, down from $7. The firm cites Wendy's continued decline in U.S. same-store-sales trends with no visibility for achieving the guided second half of 2026 improvement for the downgrade.
RBC Capital downgraded Carlyle (CG) to Sector Perform from Outperform with a price target of $58, down from $66, following Q1 results. With Carlyle recently hosting its 2026 investor day, the firm sees limited catalysts to the upside in the near-term with both RBC and consensus modeling growth accelerating going forward.
TD Cowen initiated coverage of Klarna (KLAR) with a Hold rating and $16 price target. TD believes the company has the broadest merchant coverage among the major buy now pay later providers.
Deutsche Bank resumed coverage of Genius Sports (GENI) with a Buy rating and $10 price target. The firm believes Genius continues to have "numerous ways to win" in the legacy sports betting business-to-business business to drive growth moving forward.
JPMorgan initiated coverage of Oklo (OKLO) with a Neutral rating and $83 price target. The firm wants to see further successful commercialization execution before gaining more comfort in the shares.
Goldman Sachs reinstated coverage of BioMarin (BMRN) with a Neutral rating and $69 price target following the completion of the Amicus acquisition. While the shares are trading around the value of the enzyme replacement therapy business only, BioMarin has limited near-term value-drivers and "competitive overhangs" on Voxzogo, the firm tells investors in a research note.
RBC Capital initiated coverage of Madison Air (MAIR) with an Outperform rating and $48 price target. The firm says Madison is a "high quality/highly profitable" HVAC pure-play. Stifel, Barclays, Wells Fargo, BofA, Citi, Melius Research, Vertical Research, William Blair and Baird also started coverage of the name with Buy-equivalent ratings, while Goldman Sachs and Wolfe Research initiated with Neutral-equivalent ratings.